Krishnaratne, S., Hensen, B., Cordes, J., Enstone, J. & Hargreaves, J. R. Interventions to strengthen the HIV prevention cascade: a systematic review of reviews. Lancet HIV 3, e307–e317 (2016).
Landovitz, R. J., Scott, H. & Deeks, S. G. Prevention, treatment and cure of HIV infection. Nat. Rev. Microbiol. 21, 657–670 (2023).
Brink, D. T. et al. Impact of an international HIV funding crisis on HIV infections and mortality in low-income and middle-income countries: a modelling study. Lancet HIV 12, e346-e354, (2025).
World Health Organization. HIV Drug Resistance — Brief Report (WHO, 2024).
Loosli, T. et al. Predicted dolutegravir resistance in people living with HIV in South Africa during 2020–35: a modelling study. Lancet Glob. Health 13, e698–e706 (2025).
Gandhi, R. T. et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society–USA panel. JAMA 329, 63–84 (2023).
Nöstlinger, C. et al. HIV among migrants in precarious circumstances in the EU and European economic area. Lancet HIV 9, e428–e437 (2022).
Traeger, M. W. et al. Association of HIV preexposure prophylaxis with incidence of sexually transmitted infections among individuals at high risk of HIV infection. JAMA 321, 1380–1390 (2019).
Joint United Nations Programme on HIV/AIDS. 2024 Global AIDS Report — The Urgency of Now: AIDS at a Crossroads (UNAIDS, 2024).
Coffin, J. M. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267, 483–489 (1995).
Pitman, M. C., Lau, J. S. Y., McMahon, J. H. & Lewin, S. R. Barriers and strategies to achieve a cure for HIV. Lancet HIV 5, e317–e328 (2018).
Kouyos, R. D. et al. Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. J. Infect. Dis. 201, 1488–1497 (2010).
Bezemer, D. et al. Dispersion of the HIV-1 epidemic in men who have sex with men in the Netherlands: a combined mathematical model and phylogenetic analysis. PLoS Med. 12, e1001898 (2015).
Hughes, G. J. et al. Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom. PLoS Pathog. 5, e1000590 (2009).
Wertheim, J. O. et al. Social and genetic networks of HIV-1 transmission in New York City. PLoS Pathog. 13, e1006000 (2017).
Smith, D. M. et al. A public health model for the molecular surveillance of HIV transmission in San Diego, California. AIDS 23, 225–232 (2009).
Garnett, G. P. Reductions in HIV incidence are likely to increase the importance of key population programmes for HIV control in sub-Saharan Africa. J. Int. AIDS Soc. 24, e25727 (2021).
Fauci, A. S., Redfield, R. R., Sigounas, G., Weahkee, M. D. & Giroir, B. P. Ending the HIV epidemic: a plan for the United States. JAMA 321, 844 (2019).
Tudor Hart, J. The inverse care law. Lancet 297, 405–412 (1971).
Joint United Nations Programme on HIV/AIDS. Fact Sheet — Latest Global and Regional Statistics on the Status of the AIDS Epidemic (UNAIDS, 2024).
Mansky, L. M. & Temin, H. M. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69, 5087–5094 (1995).
Cuevas, J. M., Geller, R., Garijo, R., López-Aldeguer, J. & Sanjuán, R. Extremely high mutation rate of HIV-1 in vivo. PLoS Biol. 13, e1002251 (2015).
Moutouh, L., Corbeil, J. & Richman, D. D. Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure. Proc. Natl Acad. Sci. USA 93, 6106–6111 (1996).
Wei, X. et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117–122 (1995).
Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M. & Ho, D. D. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271, 1582–1586 (1996).
Grenfell, B. T. et al. Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303, 327–332 (2004).
Goulder, P. J. R. & Walker, B. D. HIV and HLA class I: an evolving relationship. Immunity 37, 426–440 (2012).
Richman, D. D., Wrin, T., Little, S. J. & Petropoulos, C. J. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl Acad. Sci. USA 100, 4144–4149 (2003).
Wei, X. et al. Antibody neutralization and escape by HIV-1. Nature 422, 307–312 (2003).
Shankarappa, R. et al. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73, 10489–10502 (1999).
Zanini, F., Puller, V., Brodin, J., Albert, J. & Neher, R. A. In vivo mutation rates and the landscape of fitness costs of HIV-1. Virus Evol. 3, vex003 (2017).
Baxter, J. et al. Inferring the multiplicity of founder variants initiating HIV-1 infection: a systematic review and individual patient data meta-analysis. Lancet Microbe 4, e102–e112 (2023).
Keele, B. F. et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl Acad. Sci. USA 105, 7552–7557 (2008).
Alizon, S. & Fraser, C. Within-host and between-host evolutionary rates across the HIV-1 genome. Retrovirology 10, 49 (2013).
Lythgoe, K. A., Gardner, A., Pybus, O. G. & Grove, J. Short-sighted virus evolution and a germline hypothesis for chronic viral infections. Trends Microbiol. 25, 336–348 (2017).
Oberle, C. S. et al. Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs. Retrovirology 13, 62 (2016).
Korber, B. et al. Evolutionary and immunological implications of contemporary HIV-1 variation. Br. Med. Bull. 58, 19–42 (2001).
Tongo, M. et al. Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic. Virol. J. 10, 29 (2013).
Nair, M., Gettins, L., Fuller, M., Kirtley, S. & Hemelaar, J. Global and regional genetic diversity of HIV-1 in 2010–21: systematic review and analysis of prevalence. Lancet Microbe 5, 100912 (2024).
Chaudron, S. E. et al. A systematic molecular epidemiology screen reveals numerous HIV-1 superinfections in the Swiss HIV cohort study. J. Infect. Dis. 226, 1256–1266 (2022).
Casado, C. et al. High-risk sexual practices contribute to HIV-1 double infection among men who have sex with men in Madrid. AIDS Res. Hum. Retroviruses 36, 896–904 (2020).
Cornelissen, M. et al. Routine HIV-1 genotyping as a tool to identify dual infections. AIDS 21, 807 (2007).
Gao, Y. et al. First complete-genome documentation of HIV-1 intersubtype superinfection with transmissions of diverse recombinants over time to five recipients. PLoS Pathog. 17, e1009258 (2021).
Bons, E. & Regoes, R. R. Virus dynamics and phyloanatomy: merging population dynamic and phylogenetic approaches. Immunol. Rev. 285, 134–146 (2018).
Salemi, M. & Rife, B. Phylogenetics and phyloanatomy of HIV/SIV intra-host compartments and reservoirs: the key role of the central nervous system. Curr. HIV Res. 14, 110–120 (2016).
Schnell, G., Price, R. W., Swanstrom, R. & Spudich, S. Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection. J. Virol. 84, 2395–2407 (2010).
Wong, J. K. et al. In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues. J. Virol. 71, 2059–2071 (1997).
Günthard, H. F. et al. Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy. J. Virol. 73, 9404–9412 (1999).
Wong, J. K. et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278, 1291–1295 (1997).
Maldarelli, F. et al. HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science 345, 179–183 (2014).
Wagner, T. A. et al. HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection. Science 345, 570–573 (2014).
Lorenzo-Redondo, R. et al. Persistent HIV-1 replication maintains the tissue reservoir during therapy. Nature 530, 51–56 (2016).
Kearney, M. F. et al. Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy. PLoS Pathog. 10, e1004010 (2014).
Joos, B. et al. HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proc. Natl Acad. Sci. USA 105, 16725–16730 (2008).
Halvas, E. K. et al. HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus. J. Clin. Invest. 130, 5847–5857 (2020).
Simonetti, F. R. et al. Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo. Proc. Natl Acad. Sci. USA 113, 1883–1888 (2016).
Tang, Y. et al. Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy. J. Clin. Invest. 133, e167417 (2023).
Sturdevant, C. B. et al. Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection. PLoS Pathog. 11, e1004720 (2015).
Sturdevant, C. B. et al. Central nervous system compartmentalization of HIV-1 subtype C variants early and late in infection in young children. PLoS Pathog. 8, e1003094 (2012).
Goyal, R. et al. Identification of system-level features in HIV migration within a host. PLoS ONE 18, e0291367 (2023).
Alizon, S. et al. Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load. PLoS Pathog. 6, e1001123 (2010).
Hollingsworth, T. D. et al. HIV-1 transmitting couples have similar viral load set-points in Rakai, Uganda. PLoS Pathog. 6, e1000876 (2010).
Bachmann, N. et al. Parent-offspring regression to estimate the heritability of an HIV-1 trait in a realistic setup. Retrovirology 14, 33 (2017).
Fraser, C. et al. Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective. Science 343, 1243727 (2014).
Mitov, V. & Stadler, T. A practical guide to estimating the heritability of pathogen traits. Mol. Biol. Evol. 35, 756–772 (2018).
Müller, V., Fraser, C. & Herbeck, J. T. A strong case for viral genetic factors in HIV virulence. Viruses 3, 204–216 (2011).
Blanquart, F. et al. Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe. PLoS Biol. 15, e2001855 (2017).
Shirreff, G., Pellis, L., Laeyendecker, O. & Fraser, C. Transmission selects for HIV-1 strains of intermediate virulence: a modelling approach. PLoS Comput. Biol. 7, e1002185 (2011).
Herbeck, J. T. et al. Evolution of HIV virulence in response to widespread scale up of antiretroviral therapy: a modeling study. Virus Evol. 2, vew028 (2016).
Rindler, A. E. et al. The interplay between replication capacity of HIV-1 and surrogate markers of disease. J. Infect. Dis. 226, 1057–1068 (2022).
Wymant, C. et al. A highly virulent variant of HIV-1 circulating in the Netherlands. Science 375, 540–545 (2022).
Serwin, K. et al. Detection of Polish cases of highly virulent subtype B of HIV-1 originating in the Netherlands. J. Med. Virol. 95, e28154 (2023).
Bertels, F. et al. Dissecting HIV virulence: heritability of setpoint viral load, CD4+ T-cell decline, and per-parasite pathogenicity. Mol. Biol. Evol. 35, 27–37 (2018).
Kusejko, K. et al. A systematic phylogenetic approach to study the interaction of HIV-1 with coinfections, noncommunicable diseases, and opportunistic diseases. J. Infect. Dis. 220, 244–253 (2019).
Wan, C. et al. Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART. Nat. Commun. 11, 5542 (2020).
Kouyos, R. D. et al. Tracing HIV-1 strains that imprint broadly neutralizing antibody responses. Nature 561, 406–410 (2018).
Redd, A. D. et al. Longitudinal antibody responses in people who inject drugs infected with similar human immunodeficiency virus strains. J. Infect. Dis. 221, 756–765 (2020).
Opravil, M. et al. Prior therapy influences the efficacy of lamivudine monotherapy in patients with lamivudine-resistant HIV-1 infection. J. Acquir. Immune Defic. Syndr. 54, 51–58 (2010).
Castagna, A. et al. Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study). AIDS 20, 795–803 (2006).
Bartha, I. & Fellay, J. Adaptation on a genomic scale. eLife 4, e06193 (2015).
Gabrielaite, M. et al. Human immunotypes impose selection on viral genotypes through viral epitope specificity. J. Infect. Dis. 224, 2053–2063 (2021).
Holman, A. G. & Gabuzda, D. A machine learning approach for identifying amino acid signatures in the HIV env gene predictive of dementia. PLoS ONE 7, e49538 (2012).
Ogishi, M. & Yotsuyanagi, H. Prediction of HIV-associated neurocognitive disorder (HAND) from three genetic features of envelope gp120 glycoprotein. Retrovirology 15, 12 (2018).
Zeeb, M. et al. Self-reported neurocognitive complaints in the Swiss HIV cohort study: a viral genome-wide association study. Brain Commun. 6, fcae188 (2024).
Kouyos, R. D. et al. Assessing predicted HIV-1 replicative capacity in a clinical setting. PLoS Pathog. 7, e1002321 (2011).
Beerenwinkel, N. et al. Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype. Proc. Natl Acad. Sci. USA 99, 8271–8276 (2002).
Hie, B., Zhong, E. D., Berger, B. & Bryson, B. Learning the language of viral evolution and escape. Science 371, 284–288 (2021).
Igiraneza, A. B. et al. Learning patterns of HIV-1 resistance to broadly neutralizing antibodies with reduced subtype bias using multi-task learning. PLoS Comput. Biol. 20, e1012618 (2024).
Damond, F. et al. Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification. AIDS Res. Hum. Retroviruses 20, 666–672 (2004).
Hirsch, V. M., Olmsted, R. A., Murphey-Corb, M., Purcell, R. H. & Johnson, P. R. An African primate lentivirus (SIVsm) closely related to HIV-2. Nature 339, 389–392 (1989).
D’arc, M. et al. Origin of the HIV-1 group O epidemic in western lowland gorillas. Proc. Natl Acad. Sci. USA 112, E1343–E1352 (2015).
Gao, F. et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397, 436–441 (1999).
Corbet, S. et al. env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area. J. Virol. 74, 529–534 (2000).
Sauter, D. & Kirchhoff, F. Key viral adaptations preceding the AIDS pandemic. Cell Host Microbe 25, 27–38 (2019).
Keele, B. F. et al. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 313, 523–526 (2006).
Korber, B. et al. Timing the ancestor of the HIV-1 pandemic strains. Science 288, 1789–1796 (2000).
Worobey, M. et al. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 455, 661–664 (2008).
Zhu, T. et al. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 391, 594–597 (1998).
Faria, N. R. et al. The early spread and epidemic ignition of HIV-1 in human populations. Science 346, 56–61 (2014).
Worobey, M. et al. Contaminated polio vaccine theory refuted. Nature 428, 820–820 (2004).
Worobey, M. et al. 1970s and ‘Patient 0’ HIV-1 genomes illuminate early HIV/AIDS history in North America. Nature 539, 98–101 (2016).
Gilbert, M. T. P. et al. The emergence of HIV/AIDS in the Americas and beyond. Proc. Natl Acad. Sci. USA 104, 18566–18570 (2007).
Magiorkinis, G. et al. The global spread of HIV-1 subtype B epidemic. Infect. Genet. Evol. 46, 169–179 (2016).
Paraskevis, D. et al. Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach. Retrovirology 6, 49 (2009).
Drummond, A. J., Pybus, O. G., Rambaut, A., Forsberg, R. & Rodrigo, A. G. Measurably evolving populations. Trends Ecol. Evol. 18, 481–488 (2003).
Holmes, E. C. et al. The molecular epidemiology of human immunodeficiency virus type 1 in Edinburgh. J. Infect. Dis. 171, 45–53 (1995).
Lemey, P., Salemi, M. & Vandamme, A. M. (eds) The Phylogenetic Handbook: A Practical Approach to Phylogenetic Analysis and Hypothesis Testing 2nd edn (Cambridge Univ. Press, 2009).
Hassan, A. S., Pybus, O. G., Sanders, E. J., Albert, J. & Esbjörnsson, J. Defining HIV-1 transmission clusters based on sequence data. AIDS 31, 1211–1222 (2017).
Ragonnet-Cronin, M. et al. Automated analysis of phylogenetic clusters. BMC Bioinformatics 14, 317 (2013).
Blenkinsop, A. et al. Estimating the potential to prevent locally acquired HIV infections in a UNAIDS Fast-Track City, Amsterdam. eLife 11, e76487 (2022).
Hué, S., Pillay, D., Clewley, J. P. & Pybus, O. G. Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups. Proc. Natl Acad. Sci. USA 102, 4425–4429 (2005).
Marzel, A. et al. The cumulative impact of harm reduction on the Swiss HIV epidemic: cohort study, mathematical model, and phylogenetic analysis. Open Forum Infect. Dis. 5, ofy078 (2018).
Turk, T. et al. Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis. eLife 6, e28721 (2017).
Hué, S. et al. Phylogenetic analyses reveal HIV-1 infections between men misclassified as heterosexual transmissions. AIDS 28, 1967–1975 (2014).
Lai, A. et al. Contribution of transgender sex workers to the complexity of the HIV-1 epidemic in the metropolitan area of Milan. Sex. Transm. Infect. 96, 451–456 (2020).
Nguyen, H. et al. Identifying and characterizing trans women in the Swiss HIV cohort study as an epidemiologically distinct risk group. Clin. Infect. Dis. 74, 1468–1475 (2021).
Ragonnet-Cronin, M. et al. HIV transmission networks among transgender women in Los Angeles County, CA, USA: a phylogenetic analysis of surveillance data. Lancet HIV 6, e164–e172 (2019).
Truong, H.-H. M. et al. How are transgender women acquiring HIV? Insights from phylogenetic transmission clusters in San Francisco. AIDS 33, 2073 (2019).
Long, J. E. et al. HIV transmission patterns among transgender women, their cisgender male partners, and cisgender MSM in Lima, Peru: a molecular epidemiologic and phylodynamic analysis. Lancet Reg. Health Am. 6, 100121 (2022).
Kovalenko, G. et al. Phylodynamics and migration data help describe HIV transmission dynamics in internally displaced people who inject drugs in Ukraine. Proc. Natl Acad. Sci. USA Nexus 2, pgad008 (2023).
Dennis, A. M. et al. Phylogenetic insights into regional HIV transmission. AIDS 26, 1813–1822 (2012).
Dennis, A. M. et al. HIV-1 transmission clustering and phylodynamics highlight the important role of young men who have sex with men. AIDS Res. Hum. Retroviruses 34, 879–888 (2018).
Oster, A. M. et al. Demographic but not geographic insularity in HIV transmission among young black MSM. AIDS 25, 2157–2165 (2011).
Wilson, D. P. Modelling based on Australian HIV notifications data suggests homosexual age mixing is primarily assortative. J. Acquir. Immune Defic. Syndr. 51, 356–360 (2009).
Zhang, J. et al. Combining molecular network analysis and field epidemiology to quantify local HIV transmission and highlight ongoing epidemics. Int. J. Infect. Dis. 128, 187–193 (2023).
Tordoff, D. M. et al. Molecular epidemiology of individuals experiencing unstable housing or living homeless at HIV diagnosis: analysis of HIV surveillance data in King County, Washington. AIDS Behav. 26, 3459–3468 (2022).
Tordoff, D. M. et al. Combining traditional and molecular epidemiology methods to quantify local HIV transmission among foreign-born residents. AIDS 35, 655 (2021).
Skaathun, B. et al. HIV-1 transmission dynamics among people who inject drugs on the US/Mexico border during the COVID-19 pandemic: a prospective cohort study. Lancet Reg. Health Am. 33, 100751 (2024).
Okano, J. T., Sharp, K., Valdano, E., Palk, L. & Blower, S. HIV transmission and source–sink dynamics in sub-Saharan Africa. Lancet HIV 7, e209–e214 (2020).
Bbosa, N. et al. Phylogeography of HIV-1 suggests that Ugandan fishing communities are a sink for, not a source of, virus from general populations. Sci. Rep. 9, 1051 (2019).
Ratmann, O. et al. Quantifying HIV transmission flow between high-prevalence hotspots and surrounding communities: a population-based study in Rakai, Uganda. Lancet HIV 7, e173–e183 (2020).
Novitsky, V. et al. Phylodynamic analysis of HIV sub-epidemics in Mochudi, Botswana. Epidemics 13, 44–55 (2015).
De Oliveira, T. et al. Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study. Lancet HIV 4, e41–e50 (2017).
Hall, M. et al. Demographics of sources of HIV-1 transmission in Zambia: a molecular epidemiology analysis in the HPTN 071 PopART study. Lancet Microbe 5, e62–e71 (2024).
Magosi, L. E. et al. Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial — BCPP/Ya Tsie trial. eLife 11, e72657 (2022).
Kusejko, K. et al. Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV cohort study. Virus Evol. 4, vey024 (2018).
Niyukuri, D., Nyasulu, P. & Delva, W. Assessing the uncertainty around age-mixing patterns in HIV transmission inferred from phylogenetic trees. PLoS ONE 16, e0249013 (2021).
Hierholzer, J. et al. Molecular epidemiology of HIV type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina. AIDS Res. Hum. Retroviruses 18, 1339–1350 (2002).
Delgado, E. et al. Identification of CRF89_BF, a new member of an HIV-1 circulating BF intersubtype recombinant form family widely spread in South America. Sci. Rep. 11, 11442 (2021).
Gräf, T. et al. Contribution of epidemiological predictors in unraveling the phylogeographic history of HIV-1 subtype C in Brazil. J. Virol. 89, 12341–12348 (2015).
Gräf, T. et al. HIV-1 molecular diversity in Brazil unveiled by 10 years of sampling by the national genotyping network. Sci. Rep. 11, 15842 (2021).
Tanaka, T. S. O. et al. Molecular epidemiology of HIV-1 among prisoners in Central Brazil and evidence of transmission clusters. Viruses 14, 1660 (2022).
Khairunisa, S. Q. et al. 2018–2019 update on the molecular epidemiology of HIV-1 in Indonesia. AIDS Res. Hum. Retroviruses 36, 957–963 (2020).
Liao, H. et al. Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam. Virology 391, 51–56 (2009).
Salvaña, E. M. T. et al. The changing molecular epidemiology of HIV in the Philippines. Int. J. Infect. Dis. 61, 44–50 (2017).
He, X. et al. A comprehensive mapping of HIV-1 genotypes in various risk groups and regions across China based on a nationwide molecular epidemiologic survey. PLoS ONE 7, e47289 (2012).
Wang, X. et al. Phylogenetic analysis of sequences in the HIV database revealed multiple potential circulating recombinant forms in China. AIDS Res. Hum. Retroviruses 37, 694–705 (2021).
Vrancken, B. et al. Comparative circulation dynamics of the five main HIV types in China. J. Virol. 94, e00683–20 (2020).
Hemelaar, J. et al. Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis. Lancet Infect. Dis. 19, 143–155 (2019).
Castley, A. et al. A national study of the molecular epidemiology of HIV-1 in Australia 2005–2012. PLoS ONE 12, e0170601 (2017).
Dennis, A. M. et al. Rising prevalence of non-B HIV-1 subtypes in North Carolina and evidence for local onward transmission. Virus Evol. 3, vex013 (2017).
Di Giallonardo, F. et al. Increased HIV subtype diversity reflecting demographic changes in the HIV epidemic in New South Wales, Australia. Viruses 12, 1402 (2020).
Duran Ramirez, J. J. et al. Increasing frequency and transmission of HIV-1 non-B subtypes among men who have sex with men in the Swiss HIV cohort study. J. Infect. Dis. 225, 306–316 (2021).
Ragonnet-Cronin, M. et al. Transmission of non-B HIV subtypes in the United Kingdom is increasingly driven by large non-heterosexual transmission clusters. J. Infect. Dis. 213, 1410–1418 (2016).
Serwin, K. et al. Phylodynamic evolution of HIV-1 A6 sub-subtype epidemics in Poland. J. Med. Virol. 96, e29482 (2024).
Blanquart, F. et al. A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda. eLife 5, e20492 (2016).
Jovanovic, L. et al. HIV-1 subtype B spread through cross-border clusters in the Balkans: a molecular analysis in view of incidence trends. AIDS 37, 125–135 (2023).
Wertheim, J. O. et al. The global transmission network of HIV-1. J. Infect. Dis. 209, 304–313 (2014).
Lewis, F., Hughes, G. J., Rambaut, A., Pozniak, A. & Leigh Brown, A. J. Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med. 5, e50 (2008).
Marzel, A. et al. HIV-1 transmission during recent infection and during treatment interruptions as major drivers of new infections in the Swiss HIV cohort study. Clin. Infect. Dis. 62, 115–122 (2016).
Pines, H. A. et al. Concurrency and HIV transmission network characteristics among MSM with recent HIV infection. AIDS 30, 2875–2883 (2016).
Ratmann, O. et al. Sources of HIV infection among men having sex with men and implications for prevention. Sci. Transl Med. 8, 320ra2 (2016).
Volz, E. M. et al. HIV-1 transmission during early infection in men who have sex with men: a phylodynamic analysis. PLoS Med. 10, e1001568 (2013).
Rieder, P. et al. HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men. AIDS 24, 1177–1183 (2010).
Hué, S., Clewley, J. P., Cane, P. A. & Pillay, D. HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy. AIDS 18, 719–728 (2004).
Villandre, L. et al. Assessment of overlap of phylogenetic transmission clusters and communities in simple sexual contact networks: applications to HIV-1. PLoS ONE 11, e0148459 (2016).
Ragonnet-Cronin, M. L. et al. A direct comparison of two densely sampled HIV epidemics: the UK and Switzerland. Sci. Rep. 6, 32251 (2016).
Bernard, E., Azad, Y., Vandamme, A., Weait, M. & Geretti, A. HIV forensics: pitfalls and acceptable standards in the use of phylogenetic analysis as evidence in criminal investigations of HIV transmission. HIV Med. 8, 382–387 (2007).
Mehta, S. R., Schairer, C. & Little, S. Ethical issues in HIV phylogenetics and molecular epidemiology. Curr. Opin. HIV AIDS 14, 221–226 (2019).
Inzaule, S. C. et al. Recommendations on data sharing in HIV drug resistance research. PLoS Med. 20, e1004293 (2023).
Tumpney, M. et al. Human immunodeficiency virus (HIV) outbreak investigation among persons who inject drugs in Massachusetts enhanced by HIV sequence data. J. Infect. Dis. 222, S259–S267 (2020).
Hanke, K. et al. A recent human immunodeficiency virus outbreak among people who inject drugs in Munich, Germany, is associated with consumption of synthetic cathinones. Open Forum Infect. Dis. 7, ofaa192 (2020).
Roussos, S. et al. Ongoing HIV transmission following a large outbreak among people who inject drugs in Athens, Greece (2014–20). Addiction 117, 1670–1682 (2022).
Arendt, V. et al. Injection of cocaine is associated with a recent HIV outbreak in people who inject drugs in Luxembourg. PLoS ONE 14, e0215570 (2019).
Cholette, F. et al. HIV-1 phylodynamic analysis among people who inject drugs in Pakistan correlates with trends in illicit opioid trade. PLoS ONE 15, e0237560 (2020).
Cohen, M. S. et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N. Engl. J. Med. 375, 830–839 (2016).
Rodger, A. J. et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet 393, 2428–2438 (2019).
Vasylyeva, T. I. et al. Tracing the impact of public health interventions on HIV-1 transmission in Portugal using molecular epidemiology. J. Infect. Dis. 220, 233–243 (2019).
Vasylyeva, T. I. et al. Phylodynamics helps to evaluate the impact of an HIV prevention intervention. Viruses 12, 469 (2020).
Di Giallonardo, F. et al. Subtype‐specific differences in transmission cluster dynamics of HIV‐1 B and CRF01_AE in New South Wales, Australia. J. Intern. AIDS Soc. 24, e25655 (2021).
Bachmann, N. et al. Phylogenetic cluster analysis identifies virological and behavioral drivers of HIV transmission in MSM. Clin. Infect. Dis. 72, 2175–2183 (2021).
Labarile, M. et al. Quantifying and predicting ongoing human immunodeficiency virus type 1 transmission dynamics in Switzerland using a distance-based clustering approach. J. Infect. Dis. 227, 554–564 (2023).
Wertheim, J. O., Panneer, N., France, A. M., Saduvala, N. & Oster, A. M. Incident infection in high-priority HIV molecular transmission clusters in the United States. AIDS 34, 1187–1193 (2020).
Oster, A. M. et al. Identifying clusters of recent and rapid HIV transmission through analysis of molecular surveillance data. J. Acquir. Immune Defic. Syndr. 79, 543–550 (2018).
Little, S. J. et al. Using HIV networks to inform real time prevention interventions. PLoS ONE 9, e98443 (2014).
Wang, X. et al. Targeting HIV prevention based on molecular epidemiology among deeply sampled subnetworks of men who have sex with men. Clin. Infect. Dis. 61, 1462–1468 (2015).
Oster, A. M. et al. HIV cluster and outbreak detection and response: the science and experience. Am. J. Prev. Med. 61, S130–S142 (2021).
Poon, A. F. Y. et al. The impact of clinical, demographic and risk factors on rates of HIV transmission: a population-based phylogenetic analysis in British Columbia, Canada. J. Infect. Dis. 211, 926–935 (2015).
Poon, A. F. Y. et al. Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study. Lancet HIV 3, e231–e238 (2016).
Campbell, E. M. et al. Detailed transmission network analysis of a large opiate-driven outbreak of HIV infection in the United States. J. Infect. Dis. 216, 1053–1062 (2017).
McClung, R. P. et al. Response to a large HIV outbreak, Cabell County, West Virginia, 2018–2019. Am. J. Prev. Med. 61, S143–S150 (2021).
Buskin, S. E. et al. Detection and response to an HIV cluster: people living homeless and using drugs in Seattle, Washington. Am. J. Prev. Med. 61, S160–S169 (2021).
Bonsall, D. et al. A comprehensive genomics solution for HIV surveillance and clinical monitoring in low-income settings. J. Clin. Microbiol. 58, e00382–20 (2020).
Kapoor, V. et al. Validation of the VirCapSeq-VERT system for differential diagnosis, detection, and surveillance of viral infections. J. Clin. Microbiol. 62, e00612–e00623 (2023).
Koullias, Y., Sax, P. E., Fields, N. F., Walensky, R. P. & Hyle, E. P. Should we be testing for baseline integrase resistance in patients newly diagnosed with human immunodeficiency virus? Clin. Infect. Dis. 65, 1274–1281 (2017).
Hyle, E. P. et al. Clinical impact and cost-effectiveness of genotype testing at human immunodeficiency virus diagnosis in the United States. Clin. Infect. Dis. 70, 1353–1363 (2020).
Ragonnet-Cronin, M., Hodcroft, E. B. & Wertheim, J. O. Understanding disclosed and cryptic HIV transmission risk via genetic analysis: what are we missing and when does it matter? Curr. Opin. HIV AIDS 14, 205 (2019).
Kusejko, K. et al. Similar but different: integrated phylogenetic analysis of Austrian and Swiss HIV-1 sequences reveal differences in transmission patterns of the local HIV-1 epidemics. J. Acquir. Immune Defic. Syndr. 90, e4–e12 (2022).
Rossetti, B. et al. Cohort profile: a European multidisciplinary network for the fight against HIV drug resistance (EuResist network). Trop. Med. Infect. Dis. 8, 243 (2023).
de Salazar, A. et al. Transmitted drug resistance to integrase-based first-line human immunodeficiency virus antiretroviral regimens in Mediterranean Europe. Clin. Infect. Dis. 76, 1628–1635 (2023).
Paraskevis, D. et al. HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors. BMC Med. 17, 4 (2019).
Zeeb, M. et al. Addressing data management and analysis challenges in viral genomics: the Swiss HIV cohort study viral next generation sequencing database. PLoS Digit. Health 4, e0000825 (2025).
Chato, C., Kalish, M. L. & Poon, A. F. Y. Public health in genetic spaces: a statistical framework to optimize cluster-based outbreak detection. Virus Evol. 6, veaa011 (2020).
Howison, M. et al. An automated bioinformatics pipeline informing near-real-time public health responses to new HIV diagnoses in a statewide HIV epidemic. Viruses 15, 737 (2023).
Kosakovsky Pond, S. L., Weaver, S., Leigh Brown, A. J. & Wertheim, J. O. HIV-TRACE (TRAnsmission cluster engine): a tool for large scale molecular epidemiology of HIV-1 and other rapidly evolving pathogens. Mol. Biol. Evol. 35, 1812–1819 (2018).
Coltart, C. E. M. et al. Ethical considerations in global HIV phylogenetic research. Lancet HIV 5, e656–e666 (2018).
Molldrem, S. & Smith, A. K. J. Reassessing the ethics of molecular HIV surveillance in the era of cluster detection and response: toward HIV data justice. Am. J. Bioeth. 20, 10–23 (2020).
Park, S. Y., Faraci, G., Ganesh, K., Dubé, M. P. & Lee, H. Y. Portable nanopore sequencing solution for next-generation HIV drug resistance testing. J. Clin. Virol. 171, 105639 (2024).
Ode, H. et al. Population-based nanopore sequencing of the HIV-1 pangenome to identify drug resistance mutations. Sci. Rep. 14, 12099 (2024).
Mboowa, G. et al. Africa in the era of pathogen genomics: unlocking data barriers. Cell 187, 5146–5150 (2024).
Adepoju, P. The next chapter for Africa’s genomic initiatives. Lancet Infect. Dis. 24, e160 (2024).
Stadler, T. et al. Decoding Genomes: From Sequences to Phylodynamics (ed. Pečerska, J.) (ETH Zurich, 2024).
Wymant, C. et al. Easy and accurate reconstruction of whole HIV genomes from short-read sequence data with shiver. Virus Evol. 4, vey007 (2018).
Zsichla, L. et al. Comparative evaluation of open-source bioinformatics pipelines for full-length viral genome assembly. Viruses 16, 1824 (2024).
Wymant, C. et al. PHYLOSCANNER: inferring transmission from within- and between-host pathogen genetic diversity. Mol. Biol. Evol. 35, 719–733 (2018).
Edgar, R. C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792–1797 (2004).
Felsenstein, J. Inferring Phylogenies (Oxford Univ. Press, 2003).
Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol. Biol. Evol. 26, 1641–1650 (2009).
Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree 2 — approximately maximum-likelihood trees for large alignments. PLoS ONE 5, e9490 (2010).
Minh, B. Q. et al. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol. Biol. Evol. 37, 1530–1534 (2020).
Guindon, S. et al. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst. Biol. 59, 307–321 (2010).
Stamatakis, A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30, 1312–1313 (2014).
Drummond, A. J. & Rambaut, A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol. 7, 214 (2007).
Bouckaert, R. et al. BEAST 2.5: an advanced software platform for Bayesian evolutionary analysis. PLoS Comput. Biol. 15, e1006650 (2019).
To, T.-H., Jung, M., Lycett, S. & Gascuel, O. Fast dating using least-squares criteria and algorithms. Syst. Biol. 65, 82–97 (2016).
Günthard, H. F. et al. Human immunodeficiency virus drug resistance: 2018 recommendations of the International Antiviral Society–USA panel. Clin. Infect. Dis. 68, 177–187 (2019).
Drescher, S. M. et al. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV cohort study. Clin. Infect. Dis. 58, 285–294 (2014).
Mbisa, J. L. et al. Determining the origins of human immunodeficiency virus type 1 drug-resistant minority variants in people who are recently infected using phylogenetic reconstruction. Clin. Infect. Dis. 69, 1136–1143 (2019).
Zhukova, A., Cutino-Moguel, T., Gascuel, O. & Pillay, D. The role of phylogenetics as a tool to predict the spread of resistance. J. Infect. Dis. 216, S820–S823 (2017).
Kühnert, D. et al. Quantifying the fitness cost of HIV-1 drug resistance mutations through phylodynamics. PLoS Pathog. 14, e1006895 (2018).
Nee, S., Holmes, E. C., Rambaut, A. & Harvey, P. H. Inferring population history from molecular phylogenies. Phil. Trans. R. Soc. Lond. B 349, 25–31 (1995).
Pybus, O. G. et al. The epidemic behavior of the hepatitis C virus. Science 292, 2323–2325 (2001).
Stadler, T. et al. Estimating the basic reproductive number from viral sequence data. Mol. Biol. Evol. 29, 347–357 (2012).
Volz, E. M. Complex population dynamics and the coalescent under neutrality. Genetics 190, 187–201 (2012).
Stadler, T. et al. How well can the exponential-growth coalescent approximate constant-rate birth–death population dynamics? Proc. R. Soc. B 282, 20150420 (2015).
Ratmann, O. et al. Phylogenetic tools for generalized HIV-1 epidemics: findings from the PANGEA-HIV methods comparison. Mol. Biol. Evol. 34, 185–203 (2017).
Mir, D. et al. Inferring population dynamics of HIV-1 subtype C epidemics in Eastern Africa and Southern Brazil applying different Bayesian phylodynamics approaches. Sci. Rep. 8, 8778 (2018).
Leventhal, G. E. et al. Inferring epidemic contact structure from phylogenetic trees. PLoS Comput. Biol. 8, e1002413 (2012).
Metzig, C., Ratmann, O., Bezemer, D. & Colijn, C. Phylogenies from dynamic networks. PLoS Comput. Biol. 15, e1006761 (2019).
Poon, A. F. Y. Phylodynamic inference with Kernel ABC and its application to HIV epidemiology. Mol. Biol. Evol. 32, 2483–2495 (2015).
Giardina, F., Romero-Severson, E. O., Albert, J., Britton, T. & Leitner, T. Inference of transmission network structure from HIV phylogenetic trees. PLoS Comput. Biol. 13, e1005316 (2017).
Faria, N. R., Suchard, M. A., Rambaut, A. & Lemey, P. Toward a quantitative understanding of viral phylogeography. Curr. Opin. Virol. 1, 423–429 (2011).
Saulnier, E., Gascuel, O. & Alizon, S. Inferring epidemiological parameters from phylogenies using regression-ABC: a comparative study. PLoS Comput. Biol. 13, e1005416 (2017).
Voznica, J. et al. Deep learning from phylogenies to uncover the epidemiological dynamics of outbreaks. Nat. Commun. 13, 3896 (2022).
Sun, C., Fang, R., Salemi, M., Prosperi, M. & Magalis, B. R. DeepDynaForecast: phylogenetic-informed graph deep learning for epidemic transmission dynamic prediction. PLoS Comput. Biol. 20, e1011351 (2024).
Stadler, T. & Bonhoeffer, S. Uncovering epidemiological dynamics in heterogeneous host populations using phylogenetic methods. Phil. Trans. R. Soc. B 368, 20120198 (2013).
Volz, E. M. et al. Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics. Virus Evol. 3, vex014 (2017).
Rasmussen, D. A. et al. Tracking external introductions of HIV using phylodynamics reveals a major source of infections in rural KwaZulu-Natal, South Africa. Virus Evol. 4, vey037 (2018).
Reichmuth, M. L. et al. Using longitudinally sampled viral nucleotide sequences to characterize the drivers of HIV-1 transmission. HIV Med. 22, 346–359 (2021).
Ou, C. Y. et al. Molecular epidemiology of HIV transmission in a dental practice. Science 256, 1165–1171 (1992).
Romero-Severson, E. O., Bulla, I. & Leitner, T. Phylogenetically resolving epidemiologic linkage. Proc. Natl Acad. Sci. USA 113, 2690–2695 (2016).
Bartha, I. et al. Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort. BMC Infect. Dis. 13, 537 (2013).
Jost, S. et al. A patient with HIV-1 superinfection. N. Engl. J. Med. 347, 731–736 (2002).
Smith, D. M. et al. HIV drug resistance acquired through superinfection. AIDS 19, 1251–1256 (2005).
Smith, D. M. et al. Incidence of HIV superinfection following primary infection. JAMA 292, 1177–1178 (2004).
Kouyos, R. D. et al. Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clin. Infect. Dis. 52, 532–539 (2011).
Puller, V., Neher, R. & Albert, J. Estimating time of HIV-1 infection from next-generation sequence diversity. PLoS Comput. Biol. 13, e1005775 (2017).
